$AYTU
AYTU BIOPHARMA, INC

2022 Q2 Form 10-Q Financial Statement

#000155837022008952 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $27.45M $24.20M $23.13M
YoY Change 16.89% 79.49% 52.67%
Cost Of Revenue $12.61M $11.51M $10.83M
YoY Change -2.52% -17.38% 73.19%
Gross Profit $14.84M $12.69M $12.30M
YoY Change 40.68% -2906.64% 38.25%
Gross Profit Margin 54.07% 52.42% 53.18%
Selling, General & Admin $17.40M $17.36M $17.61M
YoY Change -12.95% 35.07% 37.04%
% of Gross Profit 117.21% 136.83% 143.21%
Research & Development $3.697M $3.726M $4.920M
YoY Change -22.4% 855.38% 1620.28%
% of Gross Profit 24.91% 29.37% 40.0%
Depreciation & Amortization $2.246M $500.0K $400.0K
YoY Change -304.37% 400.0% 2122.22%
% of Gross Profit 15.13% 3.94% 3.25%
Operating Expenses $21.95M $67.34M $23.59M
YoY Change 1.06% 167.08% 63.04%
Operating Profit -$7.104M -$54.66M -$11.29M
YoY Change -36.38% 112.95% 102.58%
Interest Expense -$787.0K -$55.00K $20.00K
YoY Change 59.29% -87.07% -105.28%
% of Operating Profit
Other Income/Expense, Net $999.0K $1.582M -$257.0K
YoY Change -86.01% 667.96% -93.49%
Pretax Income -$17.70M -$53.07M -$11.55M
YoY Change -5.54% 108.46% 21.27%
Income Tax $0.00 $0.00 -$3.000K
% Of Pretax Income
Net Earnings -$17.70M -$53.07M -$11.55M
YoY Change -6.83% 108.46% 21.24%
Net Earnings / Revenue -64.49% -219.32% -49.94%
Basic Earnings Per Share -$1.79 -$0.44
Diluted Earnings Per Share -$492.3K -$1.79 -$0.44
COMMON SHARES
Basic Shares Outstanding 38.57M 29.69M 26.41M
Diluted Shares Outstanding 29.69M 26.41M

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.36M $27.61M $35.28M
YoY Change -61.01% -40.62% -43.1%
Cash & Equivalents $19.36M $27.61M $35.28M
Short-Term Investments
Other Short-Term Assets $633.0K $888.0K $1.418M
YoY Change -39.02% -45.02% -86.62%
Inventory $10.85M $13.89M $16.56M
Prepaid Expenses $7.375M $7.942M $11.30M
Receivables $21.71M $27.61M $22.99M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $59.93M $77.95M $87.50M
YoY Change -43.05% -22.06% -5.44%
LONG-TERM ASSETS
Property, Plant & Equipment $6.296M $7.040M $8.139M
YoY Change -27.66% 26.67% 8977.32%
Goodwill $0.00 $8.637M $46.35M
YoY Change -100.0% -86.87% 65.0%
Intangibles $70.63M $74.43M $81.34M
YoY Change -17.35% -22.66%
Long-Term Investments
YoY Change
Other Assets $766.0K $774.0K $457.0K
YoY Change 64.73% 369.22%
Total Long-Term Assets $77.69M $90.88M $136.3M
YoY Change -51.57% -47.02% 83.66%
TOTAL ASSETS
Total Short-Term Assets $59.93M $77.95M $87.50M
Total Long-Term Assets $77.69M $90.88M $136.3M
Total Assets $137.6M $168.8M $223.8M
YoY Change -48.2% -37.83% 34.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.99M $11.13M $15.60M
YoY Change -42.94% -32.66% 118.02%
Accrued Expenses $44.19M $53.47M $50.69M
YoY Change -13.86% 23.82% 470.92%
Deferred Revenue $400.0K $100.0K $200.0K
YoY Change 100.0% -57.95%
Short-Term Debt $3.813M $3.385M $7.209M
YoY Change -51.94% -27.98%
Long-Term Debt Due $96.00K $100.0K $16.34M
YoY Change -99.42% -85.71%
Total Short-Term Liabilities $64.44M $80.36M $100.6M
YoY Change -41.12% -3.97% 289.61%
LONG-TERM LIABILITIES
Long-Term Debt $14.28M $14.17M $129.0K
YoY Change 7832.78% -16.17%
Other Long-Term Liabilities $12.81M $5.577M $560.0K
YoY Change 3508.45% 5903.62% 4824.81%
Total Long-Term Liabilities $12.81M $5.577M $560.0K
YoY Change 3508.45% 5903.62% 4824.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.44M $80.36M $100.6M
Total Long-Term Liabilities $12.81M $5.577M $560.0K
Total Liabilities $91.53M $107.7M $118.3M
YoY Change -28.55% -16.14% 118.85%
SHAREHOLDERS EQUITY
Retained Earnings -$288.5M -$270.8M -$217.7M
YoY Change 61.81% 69.99% 62.66%
Common Stock $334.6M $331.9M $323.2M
YoY Change 5.92% 14148024.47% 18077864.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $46.09M $61.14M $105.5M
YoY Change
Total Liabilities & Shareholders Equity $137.6M $168.8M $223.8M
YoY Change -48.2% -37.83% 34.23%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$17.70M -$53.07M -$11.55M
YoY Change -6.83% 108.46% 21.24%
Depreciation, Depletion And Amortization $2.246M $500.0K $400.0K
YoY Change -304.37% 400.0% 2122.22%
Cash From Operating Activities -$7.095M -$9.115M -$8.822M
YoY Change 12.91% -146.27% 201.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$41.00K -$70.00K -$3.051M
YoY Change -49.38% -77.42% 10070.0%
Cash From Investing Activities -$41.00K -$70.00K -$3.051M
YoY Change -98.31% -77.42% 10070.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.117M 1.521M 6.590M
YoY Change -109.45% -123.77% -75.66%
NET CHANGE
Cash From Operating Activities -7.095M -9.115M -8.822M
Cash From Investing Activities -41.00K -70.00K -3.051M
Cash From Financing Activities -1.117M 1.521M 6.590M
Net Change In Cash -8.253M -7.664M -5.283M
YoY Change -365.54% -138.9% -121.9%
FREE CASH FLOW
Cash From Operating Activities -$7.095M -$9.115M -$8.822M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33355935
CY2021Q1 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.79
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.71
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29689856
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18092465
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27211708
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14490219
CY2022Q1 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q1 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q1 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
dei Entity Central Index Key
EntityCentralIndexKey
0001385818
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27490412
CY2021Q2 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q2 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
aytu Debt Instrument Prepayment Option Period Of Notice Required
DebtInstrumentPrepaymentOptionPeriodOfNoticeRequired
P5D
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-425000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-75000
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
11130000
CY2021Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
19255000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
53470000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
51295000
dei Entity File Number
EntityFileNumber
001-38247
dei Entity Registrant Name
EntityRegistrantName
AYTU BIOPHARMA, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0883144
dei Entity Address Address Line1
EntityAddressAddressLine1
373 Inverness Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 206
dei Entity Address City Or Town
EntityAddressCityOrTown
Englewood
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80112
dei City Area Code
CityAreaCode
720
dei Local Phone Number
LocalPhoneNumber
437-6580
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
dei Trading Symbol
TradingSymbol
AYTU
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38574875
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27613000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49649000
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
252000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27613000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28176000
CY2022Q1 us-gaap Inventory Net
InventoryNet
13891000
CY2021Q2 us-gaap Inventory Net
InventoryNet
16339000
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7942000
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9780000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
888000
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1038000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
77947000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
105234000
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
3479000
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
5140000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3561000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3563000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
74428000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
85464000
CY2022Q1 us-gaap Goodwill
Goodwill
8637000
CY2021Q2 us-gaap Goodwill
Goodwill
65802000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
774000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
465000
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
90879000
CY2021Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
160434000
CY2022Q1 us-gaap Assets
Assets
168826000
CY2021Q2 us-gaap Assets
Assets
265668000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5258000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5939000
CY2022Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3385000
CY2021Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
7934000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
100000
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
16668000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1203000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
940000
CY2022Q1 aytu Fixed Payment Arrangements Current
FixedPaymentArrangementsCurrent
2903000
CY2021Q2 aytu Fixed Payment Arrangements Current
FixedPaymentArrangementsCurrent
3134000
CY2022Q1 aytu Contingent Value Rights Liabilities Current
ContingentValueRightsLiabilitiesCurrent
156000
CY2021Q2 aytu Contingent Value Rights Liabilities Current
ContingentValueRightsLiabilitiesCurrent
218000
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4055000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2755000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
80360000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
109438000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14167000
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
180000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2406000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2624000
CY2022Q1 aytu Fixed Payment Arrangements Non Current
FixedPaymentArrangementsNonCurrent
4237000
CY2021Q2 aytu Fixed Payment Arrangements Non Current
FixedPaymentArrangementsNonCurrent
6324000
CY2022Q1 aytu Contingent Value Rights Liabilities Noncurrent
ContingentValueRightsLiabilitiesNoncurrent
564000
CY2021Q2 aytu Contingent Value Rights Liabilities Noncurrent
ContingentValueRightsLiabilitiesNoncurrent
1177000
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
371000
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
8002000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5577000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
355000
CY2022Q1 us-gaap Liabilities
Liabilities
107682000
CY2021Q2 us-gaap Liabilities
Liabilities
128100000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33355935
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27490412
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
3000
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
3000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
331912000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
315864000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-270771000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178299000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
61144000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
137568000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
168826000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
265668000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24199000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13483000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69221000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42150000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
11513000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
13935000
us-gaap Cost Of Revenue
CostOfRevenue
31780000
us-gaap Cost Of Revenue
CostOfRevenue
24249000
CY2022Q1 us-gaap Gross Profit
GrossProfit
12686000
CY2021Q1 us-gaap Gross Profit
GrossProfit
-452000
us-gaap Gross Profit
GrossProfit
37441000
us-gaap Gross Profit
GrossProfit
17901000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3726000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
390000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10742000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
859000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9743000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6597000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28700000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18128000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7615000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6001000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23784000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16948000
CY2021Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1537000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2849000
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
4818000
us-gaap Restructuring Charges
RestructuringCharges
4875000
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
45196000
CY2021Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4286000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
64649000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
4286000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1061000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1585000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3214000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4754000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
67341000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
25214000
us-gaap Operating Expenses
OperatingExpenses
131089000
us-gaap Operating Expenses
OperatingExpenses
52699000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-54655000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-25666000
us-gaap Operating Income Loss
OperatingIncomeLoss
-93648000
us-gaap Operating Income Loss
OperatingIncomeLoss
-34798000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-55000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1555000
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1257000
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-631000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-761000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2680000
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
169000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
169000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-258000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-211000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-211000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1582000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
206000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1066000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4493000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53073000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25460000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-92582000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39291000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-110000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-53073000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-25460000
us-gaap Net Income Loss
NetIncomeLoss
-92472000
us-gaap Net Income Loss
NetIncomeLoss
-39291000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29689856
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18092465
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27211708
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14490219
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.79
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.71
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
105536000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1270000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7034000
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
379000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-53073000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
61144000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
112693000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1382000
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
53103000
CY2021Q1 aytu Adjustments To Additional Paid In Capital Estimated Fair Value Of Replacement Equity Awards
AdjustmentsToAdditionalPaidInCapitalEstimatedFairValueOfReplacementEquityAwards
432000
CY2021Q1 aytu Stock Issued During Period Value Contingent Value Rights Payouts
StockIssuedDuringPeriodValueContingentValueRightsPayouts
1000000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-25460000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
143150000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
137568000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4018000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11659000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
8000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
95015000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
379000
us-gaap Net Income Loss
NetIncomeLoss
-92472000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
61144000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2345000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
29488000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
53103000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1058000
aytu Adjustments To Additional Paid In Capital Estimated Fair Value Of Replacement Equity Awards
AdjustmentsToAdditionalPaidInCapitalEstimatedFairValueOfReplacementEquityAwards
432000
aytu Stock Issued During Period Value Contingent Value Rights Payouts
StockIssuedDuringPeriodValueContingentValueRightsPayouts
1000000
us-gaap Net Income Loss
NetIncomeLoss
-39291000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
143150000
us-gaap Profit Loss
ProfitLoss
-92472000
us-gaap Profit Loss
ProfitLoss
-39291000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8005000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5878000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
64649000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
4286000
us-gaap Share Based Compensation
ShareBasedCompensation
4018000
us-gaap Share Based Compensation
ShareBasedCompensation
2485000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-761000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2680000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-268000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
115000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
44000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-112000
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
343000
aytu Write Off Of Deferred Debt Issuance Cost Net
WriteOffOfDeferredDebtIssuanceCostNet
-193000
aytu Write Off Of Deferred Debt Issuance Cost Net
WriteOffOfDeferredDebtIssuanceCostNet
258000
us-gaap Inventory Write Down
InventoryWriteDown
352000
us-gaap Inventory Write Down
InventoryWriteDown
7227000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-211000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-152000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
335000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-647000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1764000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-91000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4390000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1406000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7673000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8099000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6156000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1252000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2293000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-52000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
27000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21728000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19687000
us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
3138000
us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
683000
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
15722000
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
15399000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
69000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3207000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-356000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12700000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32250000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
782000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4430000
aytu Payments For Fixed Payment Arrangement
PaymentsForFixedPaymentArrangement
3277000
aytu Payments For Fixed Payment Arrangement
PaymentsForFixedPaymentArrangement
3034000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
112463000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
117012000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
5968000
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
16075000
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
318000
us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
15000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
363000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2647000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18500000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22288000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1543000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49901000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48333000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27613000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46790000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27613000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46538000
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
252000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27613000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46790000
us-gaap Interest Paid Net
InterestPaidNet
3080000
us-gaap Interest Paid Net
InterestPaidNet
449000
aytu Warrants Issued
WarrantsIssued
3177000
aytu Warrants Issued
WarrantsIssued
1628000
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
473000
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
66000
aytu Fixed Payment Arrangements Included In Accrued Liabilities
FixedPaymentArrangementsIncludedInAccruedLiabilities
1575000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1058000
aytu Contingent Value Rights Payout
ContingentValueRightsPayout
1000000
aytu Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
StockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
53241000
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
104322000
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
88700000
aytu Estimated Fair Value Of Replacement Equity Awards
EstimatedFairValueOfReplacementEquityAwards
432000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27600000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-53100000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-25500000
us-gaap Net Income Loss
NetIncomeLoss
-92500000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-270800000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178300000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
us-gaap Net Income Loss
NetIncomeLoss
-39300000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21700000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19700000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Management uses estimates and assumptions relating to reporting amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying condensed consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, revenue recognition, allowance for doubtful accounts, determination of variable consideration for accruals of chargebacks, administrative fees and rebates, government rebates, returns and other allowances, allowance for inventory obsolescence, valuation of financial instruments and intangible assets, accruals for contingent liabilities, fair value of long-lived assets, the value of goodwill, income tax provision, deferred taxes and valuation allowance, determination of right-of-use assets and lease liabilities, purchase price allocations, and the depreciable lives of long-lived assets. Because of the uncertainties inherent in such estimates, actual results may differ from those estimates. Management periodically evaluates estimates used in the preparation of the financial statements for reasonableness.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Prior Period Reclassification</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain prior year amounts in the consolidated balance sheets, statements of earnings and statements of cash flows have been reclassified to conform to the current year presentation, including a reclassification made in the presentation of the U.S. Food and Drug Administration (the “FDA”) fees for commercialized products. This was previously included in general and administrative expenses and is currently recorded as a component of cost of sales on the condensed consolidated statements of operations. These reclassifications did not impact operating results or cash flows for the three and nine months ended March 31, 2022 and 2021 or its financial position as of March 31, 2022 or June 30, 2021.</p>
CY2021Q3 aytu Deferred Tax Liabilities Net Decrease Goodwill Impairment
DeferredTaxLiabilitiesNetDecreaseGoodwillImpairment
100000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69221000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42150000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
69221000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
74582000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-92472000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-55712000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
100000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
200000
aytu Number Of Product Portfolios
NumberOfProductPortfolios
3
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24199000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13483000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69221000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42150000
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
44000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
44000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-100000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24199000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13483000
CY2022Q1 aytu Inventory Write Down And Impairment
InventoryWriteDownAndImpairment
2000000.0
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
7000000.0
aytu Inventory Write Down And Impairment
InventoryWriteDownAndImpairment
2400000
us-gaap Inventory Write Down
InventoryWriteDown
7200000
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
6152000
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
1740000
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
1012000
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
3479000
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
5140000
CY2022Q1 us-gaap Depreciation
Depreciation
500000
CY2021Q1 us-gaap Depreciation
Depreciation
100000
us-gaap Depreciation
Depreciation
1300000
us-gaap Depreciation
Depreciation
100000
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1796000
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2269000
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2222000
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3346000
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9873000
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10724000
CY2022Q1 us-gaap Inventory Net
InventoryNet
13891000
CY2021Q2 us-gaap Inventory Net
InventoryNet
16339000
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
5219000
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Lessee Finance Lease Existence Of Option To Extend
LesseeFinanceLeaseExistenceOfOptionToExtend
true
CY2022Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.180
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
316000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
70000
us-gaap Operating Lease Cost
OperatingLeaseCost
942000
us-gaap Operating Lease Cost
OperatingLeaseCost
195000
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
65000
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
9000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
130000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
14000
CY2022Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
18000
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
19000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
55000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
19000
CY2022Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
3000
CY2021Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
11000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2022Q1 us-gaap Lease Cost
LeaseCost
402000
CY2021Q1 us-gaap Lease Cost
LeaseCost
99000
us-gaap Lease Cost
LeaseCost
1138000
us-gaap Lease Cost
LeaseCost
229000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3561000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3563000
CY2022Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
274000
CY2021Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
329000
CY2022Q1 aytu Operating Lease And Finance Lease Right Of Use Asset
OperatingLeaseAndFinanceLeaseRightOfUseAsset
3835000
CY2021Q2 aytu Operating Lease And Finance Lease Right Of Use Asset
OperatingLeaseAndFinanceLeaseRightOfUseAsset
3892000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1203000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
940000
CY2022Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
100000
CY2021Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
102000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2406000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2624000
CY2022Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
106000
CY2021Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
180000
CY2022Q1 aytu Operating Lease And Finance Lease Liability
OperatingLeaseAndFinanceLeaseLiability
3815000
CY2021Q2 aytu Operating Lease And Finance Lease Liability
OperatingLeaseAndFinanceLeaseLiability
3846000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y10M9D
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y5M1D
CY2022Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y11M23D
CY2021Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M19D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0744
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0662
CY2022Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0643
CY2021Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0641
us-gaap Operating Lease Payments
OperatingLeasePayments
942000
us-gaap Operating Lease Payments
OperatingLeasePayments
195000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
12000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
76000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
357000
CY2022Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
29000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1436000
CY2022Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
104000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1379000
CY2022Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
87000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
749000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
90000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
46000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4057000
CY2022Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
220000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
448000
CY2022Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
14000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3609000
CY2022Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
206000
CY2021Q2 us-gaap Goodwill
Goodwill
65802000
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
19453000
CY2021Q3 us-gaap Goodwill
Goodwill
46349000
CY2021Q4 us-gaap Goodwill
Goodwill
46349000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
37712000
CY2022Q1 us-gaap Goodwill
Goodwill
8637000
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
94220000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14906000
CY2022Q1 aytu Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
4886000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
74428000
CY2021Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2021Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2021Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
94220000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8756000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
85464000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1624000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6490000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
6477000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
6282000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5938000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
5908000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
39109000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
71828000
CY2022Q1 aytu Total Amortization Of Intangible Assets
TotalAmortizationOfIntangibleAssets
2000000.0
CY2021Q1 aytu Total Amortization Of Intangible Assets
TotalAmortizationOfIntangibleAssets
1700000
aytu Total Amortization Of Intangible Assets
TotalAmortizationOfIntangibleAssets
6100000
aytu Total Amortization Of Intangible Assets
TotalAmortizationOfIntangibleAssets
4900000
CY2022Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
4900000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
4900000
CY2021Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
4300000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
4300000
CY2022Q1 aytu Accrued Program Related Liabilities
AccruedProgramRelatedLiabilities
12058000
CY2021Q2 aytu Accrued Program Related Liabilities
AccruedProgramRelatedLiabilities
8689000
CY2022Q1 aytu Accrued Product Related Fees
AccruedProductRelatedFees
1997000
CY2021Q2 aytu Accrued Product Related Fees
AccruedProductRelatedFees
2501000
CY2022Q1 aytu Accrued Saving Offers
AccruedSavingOffers
17853000
CY2021Q2 aytu Accrued Saving Offers
AccruedSavingOffers
20148000
CY2022Q1 aytu Accrued Distributor Fees
AccruedDistributorFees
5303000
CY2021Q2 aytu Accrued Distributor Fees
AccruedDistributorFees
2710000
CY2022Q1 aytu Accrued Liabilities For Trade Partners
AccruedLiabilitiesForTradePartners
2003000
CY2021Q2 aytu Accrued Liabilities For Trade Partners
AccruedLiabilitiesForTradePartners
5421000
CY2022Q1 aytu Accrued Option Exercise And Milestone Fees Current
AccruedOptionExerciseAndMilestoneFeesCurrent
3257000
CY2021Q2 aytu Accrued Option Exercise And Milestone Fees Current
AccruedOptionExerciseAndMilestoneFeesCurrent
600000
CY2022Q1 aytu Medicaid Liabilities
MedicaidLiabilities
1487000
CY2021Q2 aytu Medicaid Liabilities
MedicaidLiabilities
1714000
CY2022Q1 aytu Return Reserve
ReturnReserve
5969000
CY2021Q2 aytu Return Reserve
ReturnReserve
6367000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3543000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3145000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
53470000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
51295000
CY2022Q1 aytu Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
3500000
CY2022Q1 aytu Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
1000000.0
CY2022Q1 aytu Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
3500000
aytu Legal And Other Fees
LegalAndOtherFees
100000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
100000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
400000
CY2022Q1 aytu Debt Instrument Interest Payment Term
DebtInstrumentInterestPaymentTerm
P18M
CY2022Q1 aytu Debt Instrument Interest Payment Extension Term
DebtInstrumentInterestPaymentExtensionTerm
P6M
CY2022Q1 aytu Interest Only Period Further Extension Term
InterestOnlyPeriodFurtherExtensionTerm
P6M
CY2022Q1 aytu Debt Instrument Term Of Trailing Months Revenue
DebtInstrumentTermOfTrailingMonthsRevenue
P12M
CY2022Q1 aytu Debt Instrument Prepayment Fee Percentage
DebtInstrumentPrepaymentFeePercentage
0.030
CY2022Q1 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
600000
us-gaap Loan Processing Fee
LoanProcessingFee
400000
CY2022Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.1537
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
400000
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.21
CY2022Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
600000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-200000
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
500000
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
1700000
CY2022Q1 us-gaap Accretion Expense
AccretionExpense
23000
CY2021Q1 us-gaap Accretion Expense
AccretionExpense
15000
us-gaap Accretion Expense
AccretionExpense
100000
us-gaap Accretion Expense
AccretionExpense
300000
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.21
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
15000000
CY2022Q1 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
638000
CY2022Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1577000
CY2022Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
206000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
14267000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
100000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14167000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
100000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5924000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
9820000
CY2022Q1 aytu Long Term Debt And Capital Lease Obligations Gross
LongTermDebtAndCapitalLeaseObligationsGross
15844000
CY2022Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1577000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
100000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14167000
CY2021Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
700000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.52
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y25D
CY2022Q1 aytu Contingent Consideration Liability Derecognized
ContingentConsiderationLiabilityDerecognized
9100000
CY2022Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
400000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33355935
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27490412
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
109588
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1270000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1522000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4018000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
15132
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
10599
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.16
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
83857
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.37
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M14D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
55611
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.51
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y8M4D
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
200000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2485000
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0001
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11064402
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1779881
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24199000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13483000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69221000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42150000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-53073000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-25460000
us-gaap Net Income Loss
NetIncomeLoss
-92472000
us-gaap Net Income Loss
NetIncomeLoss
-39291000
CY2022Q1 us-gaap Assets
Assets
168826000
CY2021Q2 us-gaap Assets
Assets
265668000

Files In Submission

Name View Source Status
0001558370-22-008952-index-headers.html Edgar Link pending
0001558370-22-008952-index.html Edgar Link pending
0001558370-22-008952.txt Edgar Link pending
0001558370-22-008952-xbrl.zip Edgar Link pending
aytu-20220331.xsd Edgar Link pending
aytu-20220331x10q.htm Edgar Link pending
aytu-20220331x10q001.jpg Edgar Link pending
aytu-20220331x10q_htm.xml Edgar Link completed
aytu-20220331xex10d1.htm Edgar Link pending
aytu-20220331xex10d1001.jpg Edgar Link pending
aytu-20220331xex31d1.htm Edgar Link pending
aytu-20220331xex31d2.htm Edgar Link pending
aytu-20220331xex32d1.htm Edgar Link pending
aytu-20220331_cal.xml Edgar Link unprocessable
aytu-20220331_def.xml Edgar Link unprocessable
aytu-20220331_lab.xml Edgar Link unprocessable
aytu-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending